Work

Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-136625

Authors: Clara Chen, Tim Disher, Muhaimen Siddiqui, Ignazia La Torre, Barry Skikne, Beatrice Suero, Heather Cameron, Roya Gavanji, Chris Cameron

Institutions: Bristol-Myers Squibb (United States), EVERSANA (Canada), University of Kansas Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097014108

Cites:

Cited by:

Related to: 10